Meet the Expert: High-Quality and Cost-Effective Plasmid Platform

Wednesday, January 27, 2021 - 15:10 to 15:30
Advanced Therapies Connect 2021 - Phacilitate's 2nd Virtual Experience - WATCH


In recent years, the demand for cell and gene therapy has increased substantially.  With the success in gene and cell therapy has also increased demand for plasmid DNA. In supplying the industry with high-quality Plasmid DNA, key prominent market challenges are capacity availability, accelerated TAT and affordability.  In this presentation, WuXi Advanced Therapies will showcase how to address these prominent challenges to provide high-quality, cost-effective and accelerated TAT for GMP like and GMP Plasmid DNA market supply to help accelerate customer’s pipeline to market.
Key Takeaways:
  • High-quality and Cost-effective Plasmid DNA Solution
  • Flexible Facility with Accelerated TAT
  • Capabilities of ATU Plasmid Platform
  • WuXi ATU GMP plasmids & Manufacturing Experience

Related Information


Dr. Shuyuan Yao
Chief Scientific Officer and Head of Research & Technology Development - Wuxi Advanced Therapies
< Back